• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型和2型糖尿病患者的微量白蛋白尿及危险因素

Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.

作者信息

Cederholm J, Eliasson B, Nilsson P M, Weiss L, Gudbjörnsdottir S

机构信息

Family Medicine and Epidemiology Section, Department of Public Health and Caring Sciences, Dag Hammarskjolds vag 14B, University Hospital, Uppsala SE-75185, Sweden.

出版信息

Diabetes Res Clin Pract. 2005 Mar;67(3):258-66. doi: 10.1016/j.diabres.2004.07.021.

DOI:10.1016/j.diabres.2004.07.021
PMID:15713359
Abstract

A prospective study of normoalbuminuric diabetic patients was performed between 1997 and 2002 on 4097 type 1 and 6513 type 2 diabetic patients from the Swedish National Diabetes Register (NDR); mean study period, 4.6 years. The strongest independent baseline risk factors for the development of microalbuminuria (20-200 microg/min) were elevated HbA(1c) and diabetes duration in both types 1 and 2 diabetic patients. Other risk factors were high BMI, elevated systolic and diastolic BP in type 2 patients, and antihypertensive therapy in type 1 patients. A subsequent larger cross-sectional study in 2002 showed that established microalbuminuria was independently associated with HbA(1c), diabetes duration, systolic BP, BMI, smoking and triglycerides in types 1 and 2 diabetic patients, and also with HDL-cholesterol in type 2 patients. Relatively few types 1 and 2 patients with microalbuminuria achieved treatment targets of HbA(1c) < 6.5% (21-48%), BP < 130/85 mmHg (33-13%), cholesterol < 5 mmol/l (48-46%), triglycerides < 1.7 mmol/l (83-48%) and BMI < 25 kg/m(2) (50-18%), respectively. In conclusion, high HbA(1c), BP and BMI were independent risk factors for the development of microalbuminuria in types 1 and 2 diabetic patients. These risk factors as well as triglycerides, HDL-cholesterol and smoking were independently associated with established microalbuminuria. Treatment targets were achieved by a relatively few patients with microalbuminuria.

摘要

1997年至2002年间,对瑞典国家糖尿病登记处(NDR)的4097例1型糖尿病患者和6513例2型糖尿病患者进行了一项关于正常白蛋白尿糖尿病患者的前瞻性研究;平均研究期为4.6年。1型和2型糖尿病患者发生微量白蛋白尿(20 - 200微克/分钟)的最强独立基线危险因素是糖化血红蛋白(HbA1c)升高和糖尿病病程。其他危险因素包括2型患者的高体重指数(BMI)、收缩压和舒张压升高,以及1型患者的抗高血压治疗。2002年随后进行的一项更大规模的横断面研究表明,已确诊的微量白蛋白尿与1型和2型糖尿病患者的HbA1c、糖尿病病程、收缩压、BMI、吸烟和甘油三酯独立相关,在2型患者中还与高密度脂蛋白胆固醇(HDL - 胆固醇)相关。相对较少的1型和2型微量白蛋白尿患者达到了糖化血红蛋白<6.5%(21% - 48%)、血压<130/85 mmHg(33% - 13%)、胆固醇<5 mmol/l(48% - 46%)、甘油三酯<1.7 mmol/l(83% - 48%)和BMI<25 kg/m²(50% - 18%)的治疗目标。总之,高HbA1c、血压和BMI是1型和2型糖尿病患者发生微量白蛋白尿的独立危险因素。这些危险因素以及甘油三酯、HDL - 胆固醇和吸烟与已确诊的微量白蛋白尿独立相关。只有相对较少的微量白蛋白尿患者达到了治疗目标。

相似文献

1
Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.1型和2型糖尿病患者的微量白蛋白尿及危险因素
Diabetes Res Clin Pract. 2005 Mar;67(3):258-66. doi: 10.1016/j.diabres.2004.07.021.
2
Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes--data from the National Diabetes Register in Sweden.吸烟与糖尿病患者糖化血红蛋白(HbA1c)值升高及微量白蛋白尿相关——来自瑞典国家糖尿病登记处的数据。
Diabetes Metab. 2004 Jun;30(3):261-8. doi: 10.1016/s1262-3636(07)70117-9.
3
Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.对1型糖尿病患者样本进行15年随访研究后的肾脏和视网膜微血管病变
J Diabetes Complications. 2007 Mar-Apr;21(2):93-100. doi: 10.1016/j.jdiacomp.2006.04.001.
4
Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.1型糖尿病患者微量白蛋白尿发生的预测因素:一项为期七年的前瞻性研究。微量白蛋白尿协作研究组
Diabet Med. 1999 Nov;16(11):918-25.
5
The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.代谢与血压控制对肾病发病率及进展的影响。对385例2型糖尿病患者的10年研究。
J Diabetes Complications. 2001 Nov-Dec;15(6):307-13. doi: 10.1016/s1056-8727(01)00176-3.
6
Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.2型糖尿病显性肾病的进展:卡萨莱蒙费拉托研究
Diabetes Care. 2003 Jul;26(7):2150-5. doi: 10.2337/diacare.26.7.2150.
7
HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.糖化血红蛋白变异性与 2 型糖尿病微量白蛋白尿的发生有关:一项 7 年的前瞻性队列研究。
Diabetologia. 2012 Dec;55(12):3163-72. doi: 10.1007/s00125-012-2700-4. Epub 2012 Aug 26.
8
HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.糖化血红蛋白(HbA1c)变异性与 2 型糖尿病微量白蛋白尿的发展:筑波川井糖尿病登记 2 号。
Diabetologia. 2012 Aug;55(8):2128-31. doi: 10.1007/s00125-012-2572-7. Epub 2012 May 12.
9
The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care.瑞典国家糖尿病登记系统:《圣文森特宣言》在糖尿病护理质量改进方面的一项实施举措。
Diabetes Care. 2003 Apr;26(4):1270-6. doi: 10.2337/diacare.26.4.1270.
10
Clinical characteristics associated with microalbuminuria in an adult diabetic population.成年糖尿病患者群体中与微量白蛋白尿相关的临床特征。
J Diabet Complications. 1990 Jan-Mar;4(1):15-20. doi: 10.1016/0891-6632(90)90059-e.

引用本文的文献

1
Glycemia Risk Index is Associated With Risk of Albuminuria Among Individuals With Type 1 Diabetes.血糖风险指数与1型糖尿病患者的蛋白尿风险相关。
J Diabetes Sci Technol. 2025 Jan 8:19322968241310850. doi: 10.1177/19322968241310850.
2
Smoking and diabetic nephropathy: An updated systematic review and meta-analysis.吸烟与糖尿病肾病:一项更新的系统评价与荟萃分析。
J Diabetes Investig. 2025 Mar;16(3):442-450. doi: 10.1111/jdi.14385. Epub 2024 Dec 27.
3
Prevalence of Diabetic Macular Edema Using Optical Coherence Tomography in Type 2 Diabetics With Nephropathy in Comparison With Type 2 Diabetics Without Nephropathy.
与无肾病的2型糖尿病患者相比,使用光学相干断层扫描技术检测2型糖尿病肾病患者黄斑水肿的患病率
Cureus. 2024 Oct 2;16(10):e70703. doi: 10.7759/cureus.70703. eCollection 2024 Oct.
4
Gender Differences in the Incidence of Nephropathy and Changes in Renal Function in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study.2型糖尿病患者肾病发病率及肾功能变化的性别差异:一项回顾性队列研究
Diabetes Metab Syndr Obes. 2024 Feb 26;17:943-957. doi: 10.2147/DMSO.S451628. eCollection 2024.
5
Relationship between Diabetic Nephropathy and Development of Diabetic Macular Edema in Addition to Diabetic Retinopathy.糖尿病肾病与除糖尿病视网膜病变外的糖尿病黄斑水肿发生之间的关系。
Biomedicines. 2023 May 22;11(5):1502. doi: 10.3390/biomedicines11051502.
6
Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related Complications.糖尿病遗漏百万人群的风险预测:识别糖尿病及相关并发症的高危个体。
Diabetes Ther. 2021 Jan;12(1):87-105. doi: 10.1007/s13300-020-00963-2. Epub 2020 Nov 14.
7
Association of smoking and cardiometabolic parameters with albuminuria in people with type 2 diabetes mellitus: a systematic review and meta-analysis.吸烟和心血管代谢参数与 2 型糖尿病患者白蛋白尿的关系:系统评价和荟萃分析。
Acta Diabetol. 2019 Aug;56(8):839-850. doi: 10.1007/s00592-019-01293-x. Epub 2019 Feb 24.
8
Cigarette smoking as a risk factor for diabetic nephropathy: A systematic review and meta-analysis of prospective cohort studies.吸烟作为糖尿病肾病的一个风险因素:一项前瞻性队列研究的系统评价和荟萃分析。
PLoS One. 2019 Feb 4;14(2):e0210213. doi: 10.1371/journal.pone.0210213. eCollection 2019.
9
Cigarette smoking and risk of albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies.吸烟与 2 型糖尿病患者蛋白尿风险的关系:一项观察性研究的系统评价和荟萃分析。
Int Urol Nephrol. 2018 May;50(5):911-922. doi: 10.1007/s11255-018-1825-x. Epub 2018 Feb 23.
10
Smoking and the risk of diabetic nephropathy in patients with type 1 and type 2 diabetes: a meta-analysis of observational studies.1型和2型糖尿病患者吸烟与糖尿病肾病风险:观察性研究的荟萃分析
Oncotarget. 2017 Oct 4;8(54):93209-93218. doi: 10.18632/oncotarget.21478. eCollection 2017 Nov 3.